Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_assertion type Assertion NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_head.
- NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_assertion description "[Expression of CD86 was higher upon N-palmitoyl-S-[2,3-bis(palmitoyl)-(2RS)-propyl]-(R)cysteinyl-alanyl-glycine (Pam3Cys) stimulation in TLR-2 R753Q polymorph AD patients compared to wild type AD patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_provenance.
- NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_assertion evidence source_evidence_literature NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_provenance.
- NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_assertion SIO_000772 19849713 NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_provenance.
- NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_assertion wasDerivedFrom befree-2016 NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_provenance.
- NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_assertion wasGeneratedBy ECO_0000203 NP771057.RA5kCB-gscZuLfU97xA5VVZ-qzw3j4ea7-I4nGZSNyun8130_provenance.